Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Activation of Calcium/Calmodulin- Dependent Protein Kinase II in Obesity Mediates Suppression of Hepatic Insulin Signaling

Texto completo
Autor(es):
Ozcan, Lale [1] ; de Souza, Jane Cristina [1] ; Harari, Alp Avi [1] ; Backs, Johannes [2, 3] ; Olson, Eric N. [4] ; Tabas, Ira [1, 5, 6]
Número total de Autores: 6
Afiliação do(s) autor(es):
[1] Columbia Univ, Dept Med, New York, NY 10032 - USA
[2] Heidelberg Univ, Dept Cardiol, Lab Cardiac Epigenet, D-69120 Heidelberg - Germany
[3] DZHK German Ctr Cardiovasc Res, D-69120 Heidelberg - Germany
[4] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 - USA
[5] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 - USA
[6] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 - USA
Número total de Afiliações: 6
Tipo de documento: Artigo Científico
Fonte: Cell Metabolism; v. 18, n. 6, p. 803-815, DEC 3 2013.
Citações Web of Science: 52
Resumo

A hallmark of obesity is selective suppression of hepatic insulin signaling ({''}insulin resistance{''}), but critical gaps remain in our understanding of the molecular mechanisms. We now report a major role for hepatic CaMKII, a calcium-responsive kinase that is activated in obesity. Genetic targeting of hepatic CaMKII, its downstream mediator p38, or the p38 substrate and stabilizer MK2 enhances insulin-induced p-Akt in palmitate-treated hepatocytes and obese mouse liver, leading to metabolic improvement. The mechanism of improvement begins with induction of ATF6 and the ATF6 target p58 IPK, a chaperone that suppresses the PERK-p-eIF2 alpha-ATF4 branch of the UPR. The result is a decrease in the ATF4 target TRB3, an inhibitor of insulin-induced p-Akt, leading to enhanced activation of Akt and its downstream metabolic mediators. These findings increase our understanding of the molecular mechanisms linking obesity to selective insulin resistance and suggest new therapeutic targets for type 2 diabetes and metabolic syndrome. (AU)

Processo FAPESP: 12/21290-4 - Metabolismo de colesterol e secreção de insulina em ilhotas de camundongos hipercolesterolêmicos: possível participação do estresse de retículo
Beneficiário:Jane Cristina de Souza Sporkens
Modalidade de apoio: Bolsas no Exterior - Estágio de Pesquisa - Pós-Doutorado